An International Conference on Neurology and Neurological Disorders will be held in Osaka, Japan. The leading specialist of the Swiss Medica clinic group, Dr. Nikolai Vorobyov, will take part in the Conference.
On November 15-16, the next International Conference on Neurology
(Neuro 2018) will be held in Osaka (Japan), the topic of which will be modern developments in the field of neurology and neuroscience. Prominent experts in the field of neurology and neurobiology will take part in the Neuro 2018. In the margins of the Conference, international symposia, business meetings, and seminars will be held. The Conference agenda includes discussion of neurogenesis, neurophysiology, neurological and neuromuscular disorders, neuroinfectious diseases, neuropathology, and brain plasticity.
The purpose of the conference is to discuss the recent advances in the identification of genetic prerequisites for common disorders. Neurogenetic disorders are widespread in most developed countries. Genetic disorders and congenital anomalies occur in about 2-5% of newborns, which is about 30% of all requests for pediatric care. Most of such disorders do not answer medical treatment or are incurable. In the Netherlands, about 10% of patients with neurological disorders have a mutated gene that is associated with a disease. Moreover, this figure increases significantly when it comes to polygenic inheritance.
It is also planned to discuss the problem of dementia, the development of which is closely related to age. This disease is significantly common in countries with an aging population. In current times, 16% of Europe’s population is older than 65, so by the 2030 year, this figure is expected to reach 25%. Only medical expenses and prevention of dementia in the Netherlands alone amount to £17 billion per year.
At the 13th International Conference on Neurology, such experts as clinicians, neurogenetics, neurologists, psychiatrists, scientists, and students from around the world will gather. They will be able to share knowledge about the genetic code underlying neurological disorders and discuss diagnostic techniques and the use of genetics and genomics as instruments for therapy development.
IMR-therapy of Dr. N.V. Vorobyov
Nikolai Vasilyevich Vorobyov, the leading specialist of the Swiss Medica clinic group, confirmed his participation in the conference. In the treatment of neurological disorders, the doctor uses IMR-therapy (Intracellular Metabolism Remediation). When using cell therapy, it can help increase the sensitivity and activity of cells. IMR-therapy has already been proven to be effective for neurological diseases, such as multiple sclerosis, type 2 diabetes, cardiovascular diseases, and joint conditions.